Boiron S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BOIRF research report →
Price Chart
About the company
Boiron S. A. is a leading pharmaceutical enterprise focused on the global development and sale of homeopathic treatments.
- CEO
- Pascal Houdayer
- IPO
- 1996
- Employees
- 2,634
- HQ
- Messimy, FR
Get TickerSpark's AI analysis on BOIRF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $546.91M
- P/E
- 11.88
- Fwd P/E
- 15.96
- PEG
- 0.35
- P/S
- 0.62
- P/B
- 0.82
- EV/EBITDA
- 4.95
- Div Yield
- 7.63%
- Gross Margin
- 72.20%
- Op Margin
- 5.15%
- Net Margin
- 5.28%
- ROE
- 6.82%
- ROIC
- 4.20%
Latest fiscal year · YoY change
- Revenue
- $500.92M+2.7%
- Gross Profit
- $365.59M+1.9%
- Op Income
- $35.39M
- Net Income
- $32.63M+187.9%
- EPS
- $1.88+189.2%
- OCF Growth
- +40.7%
- FCF Growth
- +70.1%
- 52W High
- $32.28
- 52W Low
- $24.50
- 50D MA
- $31.50
- 200D MA
- $30.80
- Beta
- 0.22
- RSI (14)
- 32
- Avg Volume
- 138
No earnings-call transcripts are available for BOIRF yet.
- Free Float
- 16.5%
- Shares Outstanding
- 17.36M
- Float Shares
- 2.87M
Our BOIRF coverage
Recent articles, reports, and earnings notes.
No research on BOIRF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BOIRF report →